Health

Maternity and Baby Brand Momcozy Launches 'Parachute Care Program' to Support Breastfeeding Journeys

NEW YORK, March 1, 2023 /PRNewswire/ -- Momcozy, the renowned maternity and baby brand endorsed by over 2 million moms globally, has announced the year-long Parachute Care Program  to support more moms' breastfeeding journeys. The brand has kicked off the first ...

2023-03-01 21:00 1822

GenFleet receives EMA approval for phase Ib/II study of GFH925 (KRAS G12C inhibitor) in combination with ERBITUX® (cetuximab) treating patients with advanced NSCLC in first-line setting

SHANGHAI, March 1, 2023 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced today that European Medicine Agency (EMA) approved the phase Ib/II study of GFH925 (KRASG12C inhibitor) in combination wit...

2023-03-01 19:00 1900

First in Class, Mabwell Announces the TGA Approval of 9MW3811 for IND

SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that its IND application of its self-developed 9MW3811 injection for tumor and pulmonary fibrosis has been approved by the Therapeutic Goods Admi...

2023-02-28 23:00 1770

Oricell Closes $45M Series B1 Financing to Expand Development of Key Products

SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Oricell Therapeutics Co., Ltd ("Oricell" or "the Company"), aChina-based innovative pharmaceutical company committed to the development of tumor cellular immunotherapeutics, today announced the close of a$45M Series B1 investment round after the completion ...

2023-02-28 21:00 2522

Gracell Biotechnologies to Participate in Oppenheimer 33rd Annual Healthcare Conference

SAN DIEGO Calif., and SUZHOU and SHANGHAI, China, Feb. 28, 2023 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of...

2023-02-28 21:00 1838

GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology

* Entered into an acquisition deal of 3 programs YONGIN, South Korea, Feb. 27, 2023 /PRNewswire/ -- GC Biopharma Corp. (006280.KS), a leading provider of biopharmaceutical products inSouth Korea, announced today that it has signed an Asset Purchase Agreement with Catalyst Biosciences (NASDAQ : ...

2023-02-28 08:53 2166

WAT Med initiates collaborative research study with The Ohio State University to test the effectiveness of EmeTerm - neuromodulation technology to manage nausea and vomiting

VANCOUVER, BC, Feb. 27, 2023 /PRNewswire/ -- The study recruits patients who suffer from chronic nausea and vomiting. EmeTerm Explore's antiemetic effectiveness will be tested and measured using subjective responses and objective physiological data from the patients.

2023-02-28 02:15 1689

Eluminex Biosciences Closes $40+ Million Series B Financing to Continue the Development of Innovative Ophthalmic Assets and Recombinant Human Collagen Technology

SUZHOU, China and SAN FRANCISCO, Feb. 27, 2023 /PRNewswire/ -- Eluminex Biosciences (Suzhou) Limited (Eluminex) officially announced today the closing of a Series B financing of over$40 million (USD). Financing was led by Cenova Capital with additional participation from Guangzhou Yuexiu Industri...

2023-02-28 01:00 1896

Gracell Biotechnologies to Report Fourth Quarter 2022 Financials on Monday, March 13, 2023

SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Feb. 27, 2023 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment o...

2023-02-27 21:00 1528

The first case of COVID pregnant mother in Guangzhou was successfully delivered by cesarean section and the newborn was in good condition; doctors treat pregnant COVID-19 patient Under Quarantine Protection

The First Case of Successful Delivery of Patient with COVID-19 in Guangzhou GUANGZHOU, China, Feb. 27, 2023 /PRNewswire/ -- "Mother and daughter are safe, the child is 2.85 kilograms." In the early morning ofNovember 1st, director of the Department of Obstetrics and Gynecology, Liang Huichao said...

2023-02-27 17:18 1799

Singleron Biotechnologies and Macrogen Europe announce a strategic alliance

Singleron Biotechnologies and Macrogen Europe are happy to announce their collaboration to combine their strengths to provide first-class single cell multi-omics sequencing solutions. COLOGNE, Germany, Feb. 27, 2023 /PRNewswire/ -- Singleron Biotechnologies , a front-runn...

2023-02-27 16:00 1675

Distinguished Acupuncturist in China, Zhaohui Zhang Publishes Paper on Neuromodulation as the Corresponding Author

NANJING, China, Feb. 26, 2023 /PRNewswire/ -- At the beginning of February 2023, Zhaohui Zhang from Jiangsu Provincial People's Hospital received a job offer from the editorial department after the Chinese Lantern Festival. As the corresponding author, he wrote the paper "Auricular Vagal Nerve Sti...

2023-02-27 09:51 1776

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

HAIKOU, China, Feb. 24, 2023 /PRNewswire/ -- China Pharma Holdings Inc. ("China Pharma" or the "Company") (NYSE American: CPHI) reported that it expects to implement a 1-for-10 reverse stock split on its common stock effectiveMonday, March 6, 2023, with trading to begin on a split-adjusted basis ...

2023-02-25 05:05 5159

Oscotec Announces Topline Results for Phase 2 Trial of Cevidoplenib

* With the efficacy comparable to rival drugs, Oscotec plans to advance to the next step, leaving the door open for partnership PANGYO, South Korea, Feb. 24, 2023 /PRNewswire/ -- Oscotec Inc. announced topline results for Phase 2 trial evaluating the efficacy, safety and tolerability of cevidop...

2023-02-24 22:00 3477

Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform

SUZHOU, China, Feb. 24, 2023 /PRNewswire/ -- On February 20, 2023, Porton Advanced Solutions Ltd. (Porton Advanced) and Yinjia (Shanghai) Biosciences Co., Ltd. (Yinjia Biosciences) announced a strategic partnership in developing core protein raw materials for cell and gene therapy (CGT) and test ...

2023-02-24 20:00 1799

Huichao Liang, An Expert on AIDS Combined with Gynecological Oncology, Receives Excellent Popular Science Worker Award

GUANGZHOU, China, Feb. 24, 2023 /PRNewswire/ -- In 2022, the selection of outstanding popular science workers inGuangzhou was successfully concluded. Dr. Huichao Liang from the Guangzhou Eighth People's Hospital, Guangzhou Medical University was ranked on the list and awarded the title of "Excell...

2023-02-24 16:37 1701

Dr. Lilly Xu Named President of Shanghai ChemPartner

SHANGHAI, Feb. 23, 2023 /PRNewswire/ -- ChemPartner announced today the appointment of Lilly Xu, Ph.D. as President of Shanghai ChemPartner. Dr. Xu is a seasoned manager with a strong portfolio ...

2023-02-24 05:53 2135

Qilian Received Notification of Deficiency from Nasdaq Related to not timely Filing of Annual Report Form 20-F

JIUQUAN, China, Feb. 23, 2023 /PRNewswire/ -- Qilian International Holding Group Ltd (NASDAQ: QLI) ("Qilian" or the "Company"), aChina-based pharmaceutical and chemical products manufacturer, today announced it has received a notice of non-compliance from Nasdaq Stock Market LLC ("Nasdaq") on Feb...

2023-02-24 05:30 3407

Structo announces a new generation of dental 3D printers powered by MSLA 2.0 for superior Total Cost of Ownership

* ST-01 is a MSLA 2.0-powered 3D printer for high throughput digital production in medium to large dental and orthodontic laboratories. * ST-32 is a semi-automated 3D printer designed for lights-out manufacturing of clear aligner models * New generation of 3D printers are powered by MSLA 2.0...

2023-02-24 00:00 2361

Rayence unveils the first X-ray detector technology utilizing SPAD technology

* Presenting the cutting-edge detector technology, 'SPAD-GS', which is 2.5 times more sensitive to X-rays and 4 times faster than ever * Implemented the world's first X-ray detector using the 'SPAD', digital pixel technology capable of single-photon detection * Being announced and drawing at...

2023-02-23 21:00 2223
1 ... 100101102103104105106 ... 273